Comparison Between Carbapenems and β-Lactam/β-Lactamase Inhibitors in the Treatment for Bloodstream Infections Caused by Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae: A Systematic Review and Meta-Analysis

A Multinational, Preregistered Cohort Study of β-Lactam/β-Lactamase Inhibitor Combinations for Treatment of Bloodstream Infections Due to Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae

(2016) Belén Gutiérrez-Gutiérrez et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Biologic Therapies and Risk of Infection and Malignancy in Patients With Inflammatory Bowel Disease: A Systematic Review and Network Meta-analysis

(2016) Stefanos Bonovas et al.   Clinical Gastroenterology and Hepatology

Bacteremic pneumonia caused by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: Appropriateness of empirical treatment matters

(2016) Wan-Ling Cheng et al.   JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION

Empiric Piperacillin-Tazobactam versus Carbapenems in the Treatment of Bacteraemia Due to Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae

(2016) Tat Ming Ng et al.   PLoS One

β-lactam and β-lactamase inhibitor combinations in the treatment of extended-spectrum β-lactamase producing Enterobacteriaceae: time for a reappraisal in the era of few antibiotic options?

(2015) Patrick N A Harris et al.   LANCET INFECTIOUS DISEASES

Meropenem versus piperacillin-tazobactam for definitive treatment of bloodstream infections due to ceftriaxone non-susceptible Escherichia coli and Klebsiella spp (the MERINO trial): study protocol for a randomised controlled trial

(2015) Patrick NA Harris et al.   Trials

In vitro and in vivo activities of piperacillin-tazobactam and meropenem at different inoculum sizes of ESBL-producing Klebsiella pneumoniae

(2014) Y. Harada et al.   CLINICAL MICROBIOLOGY AND INFECTION

Predictors of Mortality in Patients with Bacteremia of Unknown Source Due to Extended Spectrum Beta-Lactamase ProducingEscherichia coli

(2014) G. Metan et al.   JOURNAL OF CHEMOTHERAPY

Determining a clinical framework for use of cefepime and  -lactam/ -lactamase inhibitors in the treatment of infections caused by extended-spectrum- -lactamase-producing Enterobacteriaceae

(2013) H. M. Nguyen et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Impact of Cefepime Therapy on Mortality among Patients with Bloodstream Infections Caused by Extended-Spectrum-β-Lactamase-Producing Klebsiella pneumoniae and Escherichia coli

(2012) Teena Chopra et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Impact of empirical treatment in extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. bacteremia. A multicentric cohort study

(2012) Galo Peralta et al.   BMC INFECTIOUS DISEASES

Clinical outcome of extended-spectrum beta-lactamase-producing Escherichia coli bacteremia in an area with high endemicity

(2012) Kelvin K.W. To et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

Piperacillin–tazobactam as an initial empirical therapy of bacteremia caused by extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae

(2012) Cheol-In Kang et al.   JOURNAL OF INFECTION

 -Lactam/ -Lactam Inhibitor Combinations for the Treatment of Bacteremia Due to Extended-Spectrum  -Lactamase-Producing Escherichia coli: A Post Hoc Analysis of Prospective Cohorts

(2011) J. Rodriguez-Bano et al.   CLINICAL INFECTIOUS DISEASES

The effect of inappropriate therapy on bacteremia by ESBL-producing bacteria

(2011) F. G. De Rosa et al.   INFECTION

Bacteremia Due to Extended-Spectrum- -Lactamase-Producing Enterobacter cloacae: Role of Carbapenem Therapy

(2010) C.-C. Lee et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Risk factors and outcome of extended-spectrum β-lactamase-producing Enterobacter cloacae bloodstream infections

(2010) Zubair A. Qureshi et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Pharmacodynamics of empirical antibiotic monotherapies for an intensive care unit (ICU) population based on Canadian surveillance data

(2010) Sheryl A. Zelenitsky et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Comparative assessment of inoculum effects on the antimicrobial activity of amoxycillin-clavulanate and piperacillin-tazobactam with extended-spectrum β-lactamase-producing and extended-spectrum β-lactamase-non-producing Escherichia coli isolates.

(2009) L. López-Cerero et al.   CLINICAL MICROBIOLOGY AND INFECTION

Bacteraemia due to extended-spectrum  -lactamase-producing Escherichia coli (ESBL-EC) in cancer patients: clinical features, risk factors, molecular epidemiology and outcome

(2009) C. Gudiol et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Carbapenem-Resistant Enterobacteriaceae

(2008)   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Extended-spectrum β-lactamase-producing Enterobacteriaceae: an emerging public-health concern

(2008) Johann DD Pitout et al.   LANCET INFECTIOUS DISEASES

Mucosal Damage and Neutropenia Are Required for Candida albicans Dissemination

(2008) Andrew Y. Koh et al.   PLoS Pathogens